MOLECULAR PROFILING OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY IN THE MANAGEMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS)

被引：0
|
作者：
Nuzzo, C. [1 ]
Sperduti, I. [2 ]
Marchetti, A. [3 ]
Cianciulli, A. M. [2 ]
Mottolese, M. [2 ]
Buttitta, F. [3 ]
Visca, P. [1 ]
Cecere, F. L. [4 ]
Cognetti, F. [1 ]
Milella, M. [1 ]
机构：
[1] Regina Elena Inst Canc Res, Rome, Italy
[2] Regina Elena Inst Canc Res, Rome, Italy
[3] Univ G dAnnunzio, Chieti, Italy
[4] IFO Regina Elena Natl, Div Med Oncol A, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：105 / 105
页数：1
相关论文
共 50 条
  • [21] Observational retrospective study to describe the management of advanced epidermal growth factor receptor (EGFR) mutated (M plus ) non-small cell lung cancer (NSCLC) patients (pts) in Spain (NCT01795352).
    Arriola, Edurne
    Gomez, Ramon Garcia
    Diz, Pilar
    Majem, Margarita
    Martinez, Maite
    Valdivia, Agullio Javier
    Paredes, Alfredo
    Sanchez Torres, Jose Miguel
    Peralta, Sergi
    Barneto, Isidoro C.
    Carmen Gonzalez-Arenas, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
    Normanno, N.
    Rachiglio, A. M.
    Lambiase, M.
    Fenizia, F.
    Iannaccone, A.
    Chicchinelli, N.
    Morabito, A.
    Montanino, A.
    Rocco, G.
    Galetta, D.
    Montagna, S.
    Crino, L.
    Ludovini, V.
    Vincenzi, B.
    Barletta, E.
    Pinto, C.
    Ferrau, F.
    Botti, G.
    Piccirillo, M. C.
    Perrone, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
    O'Leary, Connor
    Gasper, Harry
    Sahin, Katherine B.
    Tang, Ming
    Kulasinghe, Arutha
    Adams, Mark N.
    Richard, Derek J.
    O'Byrne, Ken J.
    PHARMACEUTICALS, 2020, 13 (10) : 1 - 16
  • [24] Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
    Normanno, N.
    Rachiglio, A. M.
    Lambiase, M.
    Fenizia, F.
    Iannaccone, A.
    Chicchinelli, N.
    Morabito, A.
    Rocco, G.
    Galetta, D.
    Montagna, E. S.
    Crino, L.
    Ludovini, V.
    Vincenzi, B.
    Barletta, E.
    Pinto, C.
    Ferrau, F.
    Botti, G.
    Piccirillo, C.
    Perrone, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [25] Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
    Harrison, Peter T.
    Vyse, Simon
    Huang, Paul H.
    SEMINARS IN CANCER BIOLOGY, 2020, 61 : 167 - 179
  • [26] Complex Mutation of Epidermal Growth Factor Receptor (EGFR) in Patients with Non-Small Lung Cancer
    Arai, Hiromasa
    Tajiri, Michihiko
    Morita, Junya
    Kameda, Yohei
    Shiino, Kimihisa
    Okudela, Koji
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S497 - S498
  • [27] Inhibition of epidermal growth factor receptor pathway by epidermal growth factor antibodies in non-small cell lung cancer
    Codony-Servat, Jordi
    -Vila, Miguel Angel Molina
    Bertran-Alamillo, Jordi
    Rosell, Rafael
    D'Hondt, Erik
    CANCER RESEARCH, 2016, 76
  • [28] Audit of Epidermal Growth Factor Receptor (EGFR) Mutation Analysis in Non-Small Cell Lung Cancer (NSCLC) in an Irish Cohort
    O'Brien, O.
    Graham, D.
    McCarthy, J.
    Burke, L.
    JOURNAL OF PATHOLOGY, 2015, 237 : S24 - S24
  • [29] Population based study of the prevalence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC)
    Skov, B. G.
    Hogdall, E.
    Clementsen, P.
    Krasnik, M.
    Larsen, K. R.
    Sorensen, J. B.
    Mellemgaard, A.
    APMIS, 2012, 120 : 14 - 14
  • [30] Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations
    Zwitter, Matjaz
    Rajer, Mirjana
    Stanic, Karmen
    Vrankar, Martina
    Doma, Andrej
    Cuderman, Anka
    Grmek, Marko
    Kern, Izidor
    Kovac, Viljem
    CANCER BIOLOGY & THERAPY, 2016, 17 (08) : 833 - 839
12345